Researchers at the VIB-KU Leuven Center for Cancer Biology have identified a potential target for cancer immunotherapy. The team, led by Professor Massimiliano Mazzone found that the CDA gene is among the top upregulated ...
Jun 6, 2024
0
14
Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human Phase I trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope, ...
Jun 12, 2024
0
0
Two genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report.
Jun 5, 2024
0
0
Collagen, a major component of the extracellular matrix, plays a crucial role in tumor development. During the development of tumors ("tumorigenesis"), collagen fibers become linearized and densely deposited, hindering immune ...
May 23, 2024
0
1
A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. By automatically ...
Jun 10, 2024
0
0
When cells become tumor cells, their metabolism changes fundamentally. Researchers at the University of Basel and the University Hospital Basel have now demonstrated that this change leaves traces that could provide targets ...
May 21, 2024
0
28
Immune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University Medical Center-led research team has discovered.
Jun 12, 2024
0
2
The ecosystem that surrounds a tumor, also known as the tumor microenvironment, includes immune cells, tissues, blood vessels and other cells that interact with each other and with the tumor. Over time, the tumor shapes this ...
Jun 13, 2024
0
2
A new research paper titled "GZ17-6.02 kills PDX isolates of uveal melanoma" has been published in Oncotarget.
May 22, 2024
0
1
Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published in Proceedings of the National Academy of Sciences, Mayo Clinic ...
May 30, 2024
0
71
